Advertisement

Molecular and Cellular Biochemistry

, Volume 345, Issue 1–2, pp 215–222 | Cite as

Naringenin promote apoptosis in cerebrally implanted C6 glioma cells

  • Devan Sabarinathan
  • Palani Mahalakshmi
  • Arambakkam Janardhanam VanisreeEmail author
Article

Abstract

Naringenin (NGEN), a naturally occurring citrus flavonone, has shown cytotoxicity in various human cancer cell lines as well as inhibitory effects on tumor growth. It has been also shown to access the brain and there is an increasing interest in its therapeutic applications. The up-regulated expression of Cx43 leads to the suppression of tumorigenicity with promoted apoptotic events. In this study, we investigated the in vivo effect of NGEN in fostering apoptosis in cerebrally implanted C6 glioma cells rat model. We analysed the expression of Cx43, caspase-3, caspase-9, Cyt C, Bcl-2 and Bax in vivo by immunoblot analysis and the ultra structure of brain cells by transmission electron microscopy. Supplementation of NGEN to experimental animals modulated Bcl-2/Bax ratio and up-regulation of caspase-3 and 9. NGEN was also found to up-regulate the expression of Cx43. These findings provide evidence that NGEN’s apoptotic effect, modulation of Bcl-2/Bax ratio leads to release of Cyt C from mitochondria, thereby activation of caspase-3 and caspase-9 is mediated by enhanced expression of Cx43. These observations were well supported by the transmission electron microscopic results which showed the characteristic apoptotic features. In conclusion, our findings demonstrate that NGEN promotes apoptosis in rat C6 glioma model.

Keywords

C6 glioma Naringenin Cx43 Apoptosis Bcl-2 Bax Cyt C Caspase-3 Caspase-9 

References

  1. 1.
    Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T (1994) Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 74:1921–1926CrossRefPubMedGoogle Scholar
  2. 2.
    Cerame MA, Guthikonda M, Kohli CM (1985) Extraneural metastasis in gliosarcoma: a case report and review of the literature. Neurosurgery 17:413–418CrossRefPubMedGoogle Scholar
  3. 3.
    Sanai N, Alvarez-Buylla A, Berger MS (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353:811–822CrossRefPubMedGoogle Scholar
  4. 4.
    Stupp R, Reni M, Gatta G, Mazza E, Vecht C (2007) Anaplastic astrocytoma in adults. Crit Rev Oncol Hematol 63(1):72–80CrossRefPubMedGoogle Scholar
  5. 5.
    Lampson LA (2001) New animal models to probe brain tumor biology, therapy and immunotherapy: advantages and remaining concerns. J Neuro Oncol. 53:275–287CrossRefGoogle Scholar
  6. 6.
    Yamasaki H, Naus CCG (1996) Role of connexin genes in growth control. Carcinogenesis 17:1199–1213CrossRefPubMedGoogle Scholar
  7. 7.
    Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL (1998) Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res 58:5089–5096PubMedGoogle Scholar
  8. 8.
    Huang RP, Hossain MZ, Huang R, Gano J, Fan Y, Boynton AL (2001) Connexin 43 (cx43) enhances chemotherapyinduced apoptosis in human glioblastoma cells. Int J Cancer 92:130–138CrossRefPubMedGoogle Scholar
  9. 9.
    Udawatte C, Ripps H (2005) The spread of apoptosis through gap-junctional channels in BHK cells transfected with Cx32. Apoptosis 10:1019–1029CrossRefPubMedGoogle Scholar
  10. 10.
    Owuor ED, Kong (2002) Antioxidants and oxidants regulated signal transduction pathways. Biochem Pharmacol 64:765–770CrossRefPubMedGoogle Scholar
  11. 11.
    Vermeulen K, Van Bockstaele DR, Berneman ZN (2005) Apoptosis: mechanisms and relevance in cancer. Ann Hematol 84:627–639CrossRefPubMedGoogle Scholar
  12. 12.
    Henson PM, Bratton DL, Fadok VA (2001) Apoptotic cell removal. Curr Biol 11:795–805CrossRefGoogle Scholar
  13. 13.
    Green DR, Evan GI (2002) A matter of life and death. Cancer Cell 1:19–30CrossRefPubMedGoogle Scholar
  14. 14.
    Vincenz C, Dixit VM (1997) Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling. J Biol Chem. 272:6578–6583CrossRefPubMedGoogle Scholar
  15. 15.
    Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309–1312CrossRefPubMedGoogle Scholar
  16. 16.
    Gayathri R, Gunadharini DN, Arunkumar A, Senthilkumar K, Krishnamoorthy G, Banudevi S, Vignesh RC, Arunakaran J (2009) Effects of diallyl disulfide (DADS) on expression of apoptosis associated proteins in androgen independent human prostate cancer cells (PC-3). Mol Cell Biochem 320:197–203CrossRefPubMedGoogle Scholar
  17. 17.
    Chen D, Chen MS, Cui QC, Yang H, Dou QP (2007) Structure–proteasome–inhibitory activity relationships of dietary flavonoids in human cancer cells. Front Biosci. 12:1935–1945CrossRefPubMedGoogle Scholar
  18. 18.
    Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M (1999) HL-60 differentiating activity and flavonoid content of the readily extractable fraction prepared from citrus juices. J Agric Food Chem 47:128–135CrossRefPubMedGoogle Scholar
  19. 19.
    Kanno S, Tomizawa A, Ohtake T, Koiwai K, Ujibe M, Ishikawa M (2006) Naringenin-induced apoptosis via activation of NF-kappaB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol Lett 166:131–139CrossRefPubMedGoogle Scholar
  20. 20.
    Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ (2004) Flavonoid permeability across an in situ model of the blood–brain barrier. Free Radic Biol Med 36:592–604CrossRefPubMedGoogle Scholar
  21. 21.
    Nobuhisa N, Hiroshi S, Masaru A, Kimiyoshi H (1993) Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol 86:117–125CrossRefGoogle Scholar
  22. 22.
    Fiddo RJ, Tatham AS, Shewry PR (1995) Western blotting analysis. Methods Mol Biol 49:423–437Google Scholar
  23. 23.
    La Vecchia C, Tavani A (1998) Fruits and vegetables, and human cancer. Eur J Cancer Prev 7:3–8CrossRefPubMedGoogle Scholar
  24. 24.
    Kanno A, Ayako TA, Takako HA, Yuu OA, Ai Shouji A, Mayuko UA, Takaharu O AB, Katsuhiko KB, Masaaki ISA (2005) Inhibitory effects of Naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice. Biol Pharm Bull 28(3):527–530CrossRefPubMedGoogle Scholar
  25. 25.
    Park C, Jin CY, Kim GY, Choi IW, Kwon TK, Choi BT, Lee SJ, Lee WH, Choi YH (2008) Induction of apoptosis by esculetin in human leukemia U937 cells through activation of JNK and ERK. Toxicol Appl Pharmacol 227:219–228CrossRefPubMedGoogle Scholar
  26. 26.
    Vijayababu MR, Kanagaraj P, Arunkumar A, Ilangovan R, Aruldhas MM, Arunakaran J (2005) Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. J Cancer Res Clin Oncol 131:765–771CrossRefPubMedGoogle Scholar
  27. 27.
    Sabarinathan D, Vanisree AJ (2010) Naringenin, a flavanone alters the tumorigenic features of C6 glioma cells. Biomed Pharmacother (in press)Google Scholar
  28. 28.
    Esposti MD, Dive C (2003) Mitochondrial membrane permeabilisation by Bax/Bak. Biochem Biophys Res Commun 304:455–461CrossRefPubMedGoogle Scholar
  29. 29.
    Letai A (2005) Pharmacological manipulation of Bcl-2 family members to control cell death. J Clin Invest 115:2648–2655CrossRefPubMedGoogle Scholar
  30. 30.
    Madhavi S, Moodbidri, Neelam V, Shirsat (2005) Activated JNK brings about accelerated apoptosis of Bcl-2 overexpressing C6 glioma cells on treatment with tamoxifen. J Neurochem 92:1–9CrossRefGoogle Scholar
  31. 31.
    Amelio MD, Tino E, Cecconi F (2008) The apoptosome: emerging insights and new potential targets for drug design. Pharm Res 25:740–751CrossRefPubMedGoogle Scholar
  32. 32.
    Ramakrishnan G, Lo Muzio L, Elinos-Báez CM, Jagan S, Augustine TA, Kamaraj S, Anandakumar P, Devaki T (2009) Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells. Cell Prolif 42:229–240CrossRefPubMedGoogle Scholar
  33. 33.
    Karamitopoulou E, Cioccari L, Jakob S, Vallan C, Schaffner T, Zimmermann A, Brunner T (2007) Active caspase 3 and DNA fragmentation as markers for apoptotic cell death in primary and metastatic liver tumors. Pathology 39:558–564CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Devan Sabarinathan
    • 1
  • Palani Mahalakshmi
    • 1
  • Arambakkam Janardhanam Vanisree
    • 1
    Email author
  1. 1.Department of BiochemistryUniversity of MadrasChennaiIndia

Personalised recommendations